Jump Financial, LLC Capricor Therapeutics, Inc. Transaction History

Jump Financial, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.56 - $15.21 $185,476 - $792,441	-52,100 Closed	0 $0
Q2 2024 Aug 14, 2024	SELL	$4.63 - $7.09 $17,654 - $27,034	-3,813 Reduced 6.82%	52,100 $248,000
Q1 2024 May 13, 2024	BUY	$3.61 - $6.88 $11,237 - $21,417	3,113 Added 5.9%	55,913 $379,000
Q4 2023 Oct 21, 2024	BUY	$2.71 - $5.08 $1,897 - $3,556	700 Added 1.34%	52,800 $258,000
Q4 2023 Feb 07, 2024	BUY	$2.71 - $5.08 $143,088 - $268,224	52,800 New	52,800 $258,000
Q4 2022 Feb 13, 2023	SELL	$3.36 - $6.55 $26,896 - $52,432	-8,005 Reduced 35.42%	14,595 $56,000
Q3 2022 Nov 07, 2022	BUY	$3.61 - $6.08 $81,586 - $137,408	22,600 New	22,600 $136,000
Q1 2022 May 12, 2022	SELL	$2.83 - $5.68 $64,524 - $129,504	-22,800 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$2.89 - $4.16 $65,892 - $94,848	22,800 New	22,800 $67,000

8.13M

1.78M

1.4M

Ticker CAPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,346,200
Market Cap $450M
Description
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.